Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pluristem Therapeutics Inc.

www.pluristem.com

Latest From Pluristem Therapeutics Inc.

Execs On The Move, May 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments BioPharmaceutical

Appointments: Crescendo, Shield, Sarepta, Verona, Hansa, Astellas and Pluristem

This week’s roundup includes various high-level appointments by companies including Vencerx Therapeutics, which has elected a new CEO, Shield Therapeutics, Crescendo Biologics, Pluristem Therapeutics, Sarepta Therapeutics and Verona Pharma.

Appointments BioPharmaceutical

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical

Start-Up Quarterly Statistics, Q4 2016

A review of biopharma start-up dealmaking and financing from October through December 2016, based on data from Strategic Transactions.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Pluristem Life Systems Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Pluristem Therapeutics Inc.
  • Senior Management
  • Yaky Yanay, Pres. & Co-CEO
    Erez Egozi, CFO
    Racheli Ofir, PhD, VP, Rsch. & IP
    Hillit Shachar, MD, VP, Bus. Dev.
    Sagi Moran, VP, Ops
    Orly Amiran, VP, QA
    Lior Raviv, VP, Dev.
    Esther Lukasiewicz, MD, PhD, VP, Clinical & Medical Affairs
  • Contact Info
  • Pluristem Therapeutics Inc.
    Phone: (972) 74-710-8600
    MATAM Advanced Tech. Park
    Bldg #5
    Haifa, 31905
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register